New combo pill shows promise for bladder control in women
NCT ID NCT07312955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding tadalafil (a drug for erectile dysfunction and enlarged prostate) to solifenacin (a standard overactive bladder drug) works better than solifenacin alone for women with overactive bladder. 80 women aged 18 to 60 with symptoms for over 6 months took either both drugs or just solifenacin for 3 months. The goal was to see if the combination improved bladder symptoms like urgency and frequency more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University Hospital (Urology Department)
Cairo, Cairo Governorate, 11511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Diabetes drug class may change how the bladder behaves
- Botox vs. blood plasma: which works better for a bladder that Won't quit?
- Vibrating device aims to restore bladder control in cancer survivors
- Ankle nerve zap may ease Kids' bladder troubles
- Could a Take-Home antibiotic prescription cut unnecessary ER visits after bladder botox?
- Could probiotics calm your bladder and your anxiety?